These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 538080)

  • 1. Formation of alpha-methyldopamine ("Catecholamphetamine") from p-hydroxyamphetamine by rat brain microsomes.
    Hoffman AR; Sastry BV; Axelrod J
    Pharmacology; 1979; 19(5):256-60. PubMed ID: 538080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and occurrence of amphetamine and p-hydroxyamphetamine in tissues of the rat after injection of d-amphetamine sulfate.
    Danielson TJ; Boulton AA
    Eur J Pharmacol; 1976 Jun; 37(2):257-64. PubMed ID: 954809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative subcellular localization of para-hydroxylated derivatives of ephedrine and amphetamine in rat brain].
    El Guedri H; Rapin J; Jacquot C; Cohen Y
    C R Acad Hebd Seances Acad Sci D; 1975 Sep; 281(9):587-9. PubMed ID: 813909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of alpha-methyldopamine in rat striatum after chronic administration of d-amphetamine.
    Duffield PH; Dougan DF; Wade DN; Duffield AM
    Life Sci; 1982 May; 30(20):1701-5. PubMed ID: 7047966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of 4-hydroxyamphetamine by rat striatal homogenates.
    Cho AK; Schaffer JC; Fischer JF
    Biochem Pharmacol; 1975 Aug; 24(16):1540-2. PubMed ID: 1191311
    [No Abstract]   [Full Text] [Related]  

  • 6. Release of 3H-alpha-methyl-m-tyramine from rat striatum in vitro.
    Dorris RL
    Eur J Pharmacol; 1976 Jan; 35(1):225-8. PubMed ID: 1253825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species variation with respect to the metabolism and excretion of d-amphetamine and d,l-N-hydroxyamphetamine succinate.
    Danielson TJ; Davis BA; Boulton AA
    Can J Physiol Pharmacol; 1977 Jun; 55(3):439-43. PubMed ID: 884602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of acute and chronic injections of d-amphetamine sulfate and substantia nigra lesions on the distribution of amphetamine and para-hydroxyamphetamine in the rat brain.
    Danielson TJ; Petrali EH; Wishart TB
    Life Sci; 1976 Oct; 19(8):1265-9. PubMed ID: 994725
    [No Abstract]   [Full Text] [Related]  

  • 9. The accumulation of p-hydroxyamphetamine by brain homogenates and its role in the release of catecholamines.
    Cho AK; Fischer JF; Schaeffer JC
    Biochem Pharmacol; 1977 Aug; 26(15):1367-72. PubMed ID: 901551
    [No Abstract]   [Full Text] [Related]  

  • 10. Amphetamine, p-hydroxyamphetamine and beta-phenethylamine in mouse brain and urine after (-)- and (+)-deprenyl administration.
    Philips SR
    J Pharm Pharmacol; 1981 Nov; 33(11):739-41. PubMed ID: 6118419
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood-brain barrier. II. Kinetics of distribution of 3H-parahydroxyamphetamine in brain structures after intravenous administration in the rat].
    Lindenbaum A; Marcher K; Wepierre J; Cohen Y
    Arch Int Pharmacodyn Ther; 1975 May; 215(1):168-76. PubMed ID: 1164084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.
    Hiramatsu M; Kumagai Y; Unger SE; Cho AK
    J Pharmacol Exp Ther; 1990 Aug; 254(2):521-7. PubMed ID: 1974641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive radioenzymatic assay for catechol drugs.
    Durrett LR; Ziegler MG
    J Neurosci Res; 1980; 5(6):587-98. PubMed ID: 7205995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
    Brannan T; Prikhojan A; Yahr MD
    J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Methyldopamine, a key intermediate in the metabolic disposition of 3,4-methylenedioxyamphetamine in vivo in dog and monkey.
    Midha KK; Hubbard JW; Bailey K; Cooper JK
    Drug Metab Dispos; 1978; 6(6):623-30. PubMed ID: 33023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of the metabolite p-hydroxyamphetamine to the central actions of p-methoxyamphetamine.
    Kaminskas LM; Irvine RJ; Callaghan PD; White JM; Kirkbride P
    Psychopharmacology (Berl); 2002 Mar; 160(2):155-60. PubMed ID: 11875633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective involvement of cytochrome P450 2D subfamily in in vivo 4-hydroxylation of amphetamine in rat.
    Law MY; Slawson MH; Moody DE
    Drug Metab Dispos; 2000 Mar; 28(3):348-53. PubMed ID: 10681381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and localization of p-hydroxy-d-amphetamine in rat brain.
    Jori A; Caccia S; Guiso G; Garattini S
    Eur J Pharmacol; 1978 Dec; 52(3-4):361-5. PubMed ID: 729645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective storage of p-hydroxy-d-amphetamine in the dopaminergic nerve terminals.
    Jori A; Caccia S; Guiso A; Ballabio M; Garattini S
    Biochem Pharmacol; 1979 Apr; 28(7):1205-7. PubMed ID: 444278
    [No Abstract]   [Full Text] [Related]  

  • 20. 3-O-methyl-alpha-methyldopamine, a urinary metabolite of p-methoxyamphetamine in dog and monkey.
    Hubbard JW; Bailey K; Midha KK; Cooper JK
    Drug Metab Dispos; 1981; 9(3):250-4. PubMed ID: 6113935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.